These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
77 related items for PubMed ID: 15894113
1. Identification of NH(2)-terminal amino acid residues essential for the biological activity of leukotactin-1. Lee JK, Kim HS, Im SA, Kim K, Kwon BS, Lee CK. Immunol Lett; 2005 Jun 15; 99(1):63-8. PubMed ID: 15894113 [Abstract] [Full Text] [Related]
2. Truncation of NH2-terminal amino acid residues increases agonistic potency of leukotactin-1 on CC chemokine receptors 1 and 3. Lee JK, Lee EH, Yun YP, Kim K, Kwack K, Na DS, Kwon BS, Lee CK. J Biol Chem; 2002 Apr 26; 277(17):14757-63. PubMed ID: 11832479 [Abstract] [Full Text] [Related]
3. Molecular cloning of leukotactin-1: a novel human beta-chemokine, a chemoattractant for neutrophils, monocytes, and lymphocytes, and a potent agonist at CC chemokine receptors 1 and 3. Youn BS, Zhang SM, Lee EK, Park DH, Broxmeyer HE, Murphy PM, Locati M, Pease JE, Kim KK, Antol K, Kwon BS. J Immunol; 1997 Dec 01; 159(11):5201-5. PubMed ID: 9548457 [Abstract] [Full Text] [Related]
4. Alanine scanning mutagenesis of the chemokine receptor CCR3 reveals distinct extracellular residues involved in recognition of the eotaxin family of chemokines. Duchesnes CE, Murphy PM, Williams TJ, Pease JE. Mol Immunol; 2006 Mar 01; 43(8):1221-31. PubMed ID: 16102831 [Abstract] [Full Text] [Related]
5. Determinants of high-affinity binding and receptor activation in the N-terminus of CCL-19 (MIP-3 beta). Ott TR, Lio FM, Olshefski D, Liu XJ, Struthers RS, Ling N. Biochemistry; 2004 Mar 30; 43(12):3670-8. PubMed ID: 15035637 [Abstract] [Full Text] [Related]
6. Functional analysis of chemically synthesized derivatives of the human CC chemokine CCL15/HCC-2, a high affinity CCR1 ligand. Escher SE, Forssmann U, Frimpong-Boateng A, Adermann K, Vakili J, Sticht H, Detheux M. J Pept Res; 2004 Jan 30; 63(1):36-47. PubMed ID: 14984572 [Abstract] [Full Text] [Related]
7. Identification of a truncated form of the CC chemokine CK beta-8 demonstrating greatly enhanced biological activity. Macphee CH, Appelbaum ER, Johanson K, Moores KE, Imburgia CS, Fornwald J, Berkhout T, Brawner M, Groot PH, O'Donnell K, O'Shannessy D, Scott G, White JR. J Immunol; 1998 Dec 01; 161(11):6273-9. PubMed ID: 9834116 [Abstract] [Full Text] [Related]
8. Construction, purification and biological activities of recombinant human interleukin-2 analogs. Boone T, Chazin V, Kenney W, Swanson E, Altrock B. Dev Biol Stand; 1988 Dec 01; 69():157-68. PubMed ID: 3066670 [Abstract] [Full Text] [Related]
9. Functional redundancy of the human CCL4 and CCL4L1 chemokine genes. Howard OM, Turpin JA, Goldman R, Modi WS. Biochem Biophys Res Commun; 2004 Jul 30; 320(3):927-31. PubMed ID: 15240137 [Abstract] [Full Text] [Related]
10. Solution structure of the human CC chemokine 2: A monomeric representative of the CC chemokine subtype. Sticht H, Escher SE, Schweimer K, Forssmann WG, Rösch P, Adermann K. Biochemistry; 1999 May 11; 38(19):5995-6002. PubMed ID: 10320325 [Abstract] [Full Text] [Related]
11. Leukotactin-1/CCL15-induced chemotaxis signaling through CCR1 in HOS cells. Ko J, Kim IS, Jang SW, Lee YH, Shin SY, Min DS, Na DS. FEBS Lett; 2002 Mar 27; 515(1-3):159-64. PubMed ID: 11943214 [Abstract] [Full Text] [Related]
12. Analysis of eosinophils and myeloid progenitor responses to modified forms of MPIF-2. Grzegorzewski KJ, Yao XT, Kreider B, Olsen HS, Morris TS, Zhang L, Sanyal I, Nardelli B, Zukauskas D, Brewer L, Bong GW, Kim Y, Garotta G, Salcedo TW. Cytokine; 2001 Feb 21; 13(4):209-19. PubMed ID: 11237428 [Abstract] [Full Text] [Related]
13. Regulation of human LZIP expression by NF-kappaB and its involvement in monocyte cell migration induced by Lkn-1. Jang SW, Kim YS, Kim YR, Sung HJ, Ko J. J Biol Chem; 2007 Apr 13; 282(15):11092-100. PubMed ID: 17296613 [Abstract] [Full Text] [Related]
14. The allergy-associated chemokine receptors CCR3 and CCR5 can be inactivated by the modified chemokine NNY-CCL11. Manns J, Rieder S, Escher S, Eilers B, Forssmann WG, Elsner J, Forssmann U. Allergy; 2007 Jan 13; 62(1):17-24. PubMed ID: 17156337 [Abstract] [Full Text] [Related]
15. Amino acids in the COOH-terminal region of the oxytocin receptor third intracellular domain are important for receptor function. Zhong M, Parish B, Murtazina DA, Ku CY, Sanborn BM. Am J Physiol Endocrinol Metab; 2007 Apr 13; 292(4):E977-84. PubMed ID: 17148753 [Abstract] [Full Text] [Related]
16. Structure-activity study of LVV-hemorphin-7: angiotensin AT4 receptor ligand and inhibitor of insulin-regulated aminopeptidase. Lee J, Mustafa T, McDowall SG, Mendelsohn FA, Brennan M, Lew RA, Albiston AL, Chai SY. J Pharmacol Exp Ther; 2003 Apr 13; 305(1):205-11. PubMed ID: 12649370 [Abstract] [Full Text] [Related]
17. Differential CCR1-mediated chemotaxis signaling induced by human CC chemokine HCC-4/CCL16 in HOS cells. Kim IS, Jang SW, Sung HJ, Lee JS, Ko J. FEBS Lett; 2005 Nov 07; 579(27):6044-8. PubMed ID: 16226254 [Abstract] [Full Text] [Related]
18. C-terminal amino acid residue loss for deprotonated peptide ions containing glutamic acid, aspartic acid, or serine residues at the C-terminus. Li Z, Yalcin T, Cassady CJ. J Mass Spectrom; 2006 Jul 07; 41(7):939-49. PubMed ID: 16810639 [Abstract] [Full Text] [Related]
19. Leukotactin-1/CCL15 induces cell migration and differentiation of human eosinophilic leukemia EoL-1 cells through PKCdelta activation. Lee JS, Kim IS. Mol Biol Rep; 2010 Jun 07; 37(5):2149-56. PubMed ID: 19669929 [Abstract] [Full Text] [Related]
20. The last five amino acid residues at the C-terminus of PRK1/PKN is essential for full lipid responsiveness. Lim WG, Zhu Y, Wang CH, Tan BJ, Armstrong JS, Dokland T, Yang H, Zhu YZ, Teo TS, Duan W. Cell Signal; 2005 Sep 07; 17(9):1084-97. PubMed ID: 15993750 [Abstract] [Full Text] [Related] Page: [Next] [New Search]